Study Phase |
Phase 1-2 |
Therapeutic Area |
Cancers |
Indication | Solid tumors |
Sponsor | Institut de Recherches Internationales Servier |
Active substance/ Medical device |
S064315 |
Active Substance Code | S064315 |
Protocol Code | CL1-64315-003 |
EudraCT Code | 2019-000998-23 |
Results summary | READ MORE |
To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.